• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/12

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

12 Cards in this Set

  • Front
  • Back

Cyclophosamide


Mechanism, application, side effect, type

Cross-linking of DNA, Leukemia, myelosuppresion and secondary tumors,


Alkylating Agent



Methotrexate


Mechanism, application, side effect, type

Reduction of folic acid, combination treatments, myelosuppresion, metabolite

5-Flurouracil


Mechanism, application, side effect, type

Interferes with conversion of deoxyuridylate to deoxythmidylate, blocks S phase, myelosuppresion and hepatotoxicity, antimetabolite

Doxorubicin


Mechanism, application, side effect, type

Use of superoxide to cause strand breaks


blood cancer, sarcomas, adenocarcinomas


Cardiotoxicity


Intercalating

Bleomycin


Mechanism, application, side effect, type

Iron-chelating, creates superoxide by forming Fe3+


Hematopoetic and squamous cell cancers


Hyperpigmentation


Intercalating



Gemcitabine


Mechanism, application, side effect, type

Use of two flourines to stop DNA synthesis


N/A


N/A


Intercalating

Taxanes


Mechanism, application, side effect, type

Prevent breaking down of microtubles


Metastatic adenocarcinomas


Neurotoxic and alopecia


Microtubule-based



Vinca Alkaloids - Vincristine/Vinblastine


Mechanism, application, side effect, type

Prevent initiation formation of microtubules


Hematalogic cancers and solid epithelia carcinomas


Myelosuppression and alopecia


Microtubule-based

Anthracylines - Doxorubicin, podophyllins


Mechanism, application, side effect, type

Prevent the resealing after the cutting of topoisomerase II


(Etoposide) First line of treatment of small cell lung cancer.


Myelosuppression and alopecia


Topisomerase inhibitor



Camptothecins


Mechanism + Two molecules, Toxicity, Type

Bind to Topo 1: DNA Complex


Topotecan and Irinotecan (Prodrug)


Myelosuppression and Neutropenia


Topisomerase inhibitor

Cisplatin


Mechanism, Type

Binds to Guanine N7 position and causes cell death


Platinum Drug




Oxaliplatin


Mechanism, application, side effect, type

Recruitment of HMG to cause cell kink and eventually death


Last option type treatment


Myelosuppresiom and renal failure


Platinum Drug